Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

325 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reconciling healthcare professional and patient perspectives in the development of disease activity and response criteria in connective tissue disease-related interstitial lung diseases.
Saketkoo LA, Mittoo S, Frankel S, LeSage D, Sarver C, Phillips K, Strand V, Matteson EL; OMERACT Connective Tissue Disease–Interstitial Lung Diseases Working Group; OMERACT Connective Tissue Disease-Interstitial Lung Diseases Working Group. Saketkoo LA, et al. J Rheumatol. 2014 Apr;41(4):792-8. doi: 10.3899/jrheum.131251. Epub 2014 Feb 1. J Rheumatol. 2014. PMID: 24488412 Free PMC article. Review.
Ziritaxestat, a Novel Autotaxin Inhibitor, and Lung Function in Idiopathic Pulmonary Fibrosis: The ISABELA 1 and 2 Randomized Clinical Trials.
Maher TM, Ford P, Brown KK, Costabel U, Cottin V, Danoff SK, Groenveld I, Helmer E, Jenkins RG, Milner J, Molenberghs G, Penninckx B, Randall MJ, Van Den Blink B, Fieuw A, Vandenrijn C, Rocak S, Seghers I, Shao L, Taneja A, Jentsch G, Watkins TR, Wuyts WA, Kreuter M, Verbruggen N, Prasad N, Wijsenbeek MS; ISABELA 1 and 2 Investigators. Maher TM, et al. JAMA. 2023 May 9;329(18):1567-1578. doi: 10.1001/jama.2023.5355. JAMA. 2023. PMID: 37159034 Free PMC article.
High-resolution CT phenotypes in pulmonary sarcoidosis: a multinational Delphi consensus study.
Desai SR, Sivarasan N, Johannson KA, George PM, Culver DA, Devaraj A, Lynch DA, Milne D, Renzoni E, Nunes H, Sverzellati N, Spagnolo P, Baughman RP, Yadav R, Piciucchi S, Walsh SLF, Kouranos V, Wells AU; Sarcoid Delphi Group. Desai SR, et al. Lancet Respir Med. 2024 May;12(5):409-418. doi: 10.1016/S2213-2600(23)00267-9. Epub 2023 Dec 14. Lancet Respir Med. 2024. PMID: 38104579 Review.
Prevalence of SARS-COV-2 infection and outcomes in Greek sarcoidosis patients.
Kotsiou O, Kirgou P, Tzouvelekis A, Kolilekas L, Manali E, Papiris S, Papakosta D, Antoniou K, Papanikolaou I, Steiropoulos P, Tomos I, Karampitsakos T, Levounets A, Fouka E, Spyropoulos G, Mastrodimou S, Papaioannou O, Kallieri M, Kosmidou N, Bizymi N, Zikos N, Dimeas I, Malli F, Daniil Z. Kotsiou O, et al. Among authors: antoniou k. Sarcoidosis Vasc Diffuse Lung Dis. 2024 Dec 10;41(4):e2024055. doi: 10.36141/svdld.v41i4.15661. Sarcoidosis Vasc Diffuse Lung Dis. 2024. PMID: 39655591
Beneficial Impact of Vaccination Against SARS-CoV-2 on the Mental Health of IPF Patients.
Tomos I, Papaioannou AI, Daniil ZI, Dimeas IE, Kirgou P, Gogali A, Tatsis K, Papanikolaou I, Tzilas V, Tzouvelekis A, Tsiri P, Steiropoulos P, Ntolios P, Xyfteri A, Antoniou K, Symvoulakis E, Haritou A, Maniati M, Kolilekas L, Antonogiannaki EM, Apollonatou V, Kallieri M, Samaras K, Loukides S, Karakatsani A, Bouros D, Manali E, Papiris S. Tomos I, et al. Among authors: antoniou k. Adv Respir Med. 2024 Nov 6;92(6):466-471. doi: 10.3390/arm92060042. Adv Respir Med. 2024. PMID: 39584853 Free PMC article.
Effect of mepolizumab in airway remodeling in patients with late-onset severe asthma with an eosinophilic phenotype.
Domvri K, Tsiouprou I, Bakakos P, Steiropoulos P, Katsoulis K, Kostikas K, Antoniou KM, Papaioannou AI, Rovina N, Katsaounou P, Papamitsou T, Pastelli N, Tryfon S, Fouka E, Papakosta D, Loukides S, Porpodis K. Domvri K, et al. Among authors: antoniou km. J Allergy Clin Immunol. 2024 Nov 7:S0091-6749(24)01168-0. doi: 10.1016/j.jaci.2024.10.024. Online ahead of print. J Allergy Clin Immunol. 2024. PMID: 39521278 Free article.
Multi-level therapeutic actions of cannabidiol in ketamine-induced schizophrenia psychopathology in male rats.
Brakatselos C, Polissidis A, Ntoulas G, Asprogerakas MZ, Tsarna O, Vamvaka-Iakovou A, Nakas G, Delis A, Tzimas P, Skaltsounis L, Silva J, Delis F, Oliveira JF, Sotiropoulos I, Antoniou K. Brakatselos C, et al. Among authors: antoniou k. Neuropsychopharmacology. 2024 Dec;50(2):388-400. doi: 10.1038/s41386-024-01977-1. Epub 2024 Sep 6. Neuropsychopharmacology. 2024. PMID: 39242923
325 results